261 related articles for article (PubMed ID: 26942290)
61. Toward clinical and molecular dissection of frontonasal dysplasia with facial skin polyps: From Pai syndrome to differential diagnosis through a series of 27 patients.
Lehalle D; Bruel AL; Vitobello A; Denommé-Pichon AS; Duffourd Y; Assoum M; Amiel J; Baujat G; Bessieres B; Bigoni S; Burglen L; Captier G; Dard R; Edery P; Fortunato F; Geneviève D; Goldenberg A; Guibaud L; Héron D; Holder-Espinasse M; Lederer D; Lopez Grondona F; Grotto S; Marlin S; Nadeau G; Picard A; Rossi M; Roume J; Sanlaville D; Saugier-Veber P; Triau S; Valenzuela Palafoll MI; Vanlerberghe C; Van Maldergem L; Vezain M; Vincent-Delorme C; Zivi E; Thevenon J; Vabres P; Thauvin-Robinet C; Callier P; Faivre L
Am J Med Genet A; 2022 Jul; 188(7):2036-2047. PubMed ID: 35445792
[TBL] [Abstract][Full Text] [Related]
62. Encephalocraniocutaneous lipomatosis: magnetic resonance imaging findings in a child.
Dhouib A; Hanquinet S; La Scala GC
J Pediatr; 2013 Jul; 163(1):297.e1. PubMed ID: 23452587
[No Abstract] [Full Text] [Related]
63. Neuroimaging Findings in Encephalocraniocutaneous Lipomatosis.
Michael GA; Poretti A; Huisman TA
Pediatr Neurol; 2015 Nov; 53(5):462-3. PubMed ID: 26344330
[No Abstract] [Full Text] [Related]
64. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors.
Rivera B; Gayden T; Carrot-Zhang J; Nadaf J; Boshari T; Faury D; Zeinieh M; Blanc R; Burk DL; Fahiminiya S; Bareke E; Schüller U; Monoranu CM; Sträter R; Kerl K; Niederstadt T; Kurlemann G; Ellezam B; Michalak Z; Thom M; Lockhart PJ; Leventer RJ; Ohm M; MacGregor D; Jones D; Karamchandani J; Greenwood CM; Berghuis AM; Bens S; Siebert R; Zakrzewska M; Liberski PP; Zakrzewski K; Sisodiya SM; Paulus W; Albrecht S; Hasselblatt M; Jabado N; Foulkes WD; Majewski J
Acta Neuropathol; 2016 Jun; 131(6):847-63. PubMed ID: 26920151
[TBL] [Abstract][Full Text] [Related]
65. Encephalocraniocutaneous lipomatosis: a review of its clinical pathology and neurosurgical indications.
Ayer RE; Zouros A
J Neurosurg Pediatr; 2011 Sep; 8(3):316-20. PubMed ID: 21882925
[TBL] [Abstract][Full Text] [Related]
66. Clinical and Neuroimaging Features of Encephalocraniocutaneous Lipomatosis.
de Moraes MPM; Ferreira de Abrantes F; Tonholo Silva TY; Pedroso JL; Marussi VHR; Meneses A; Barsottini OGP
Neurology; 2021 Oct; 97(16):785-786. PubMed ID: 34475128
[No Abstract] [Full Text] [Related]
67. A Filipino male with encephalocraniocutaneous lipomatosis (Haberland's syndrome).
Pardo IA; Nicolas ME
J Dermatol Case Rep; 2013 Jun; 7(2):46-8. PubMed ID: 23858340
[TBL] [Abstract][Full Text] [Related]
68. Encephalocraniocutaneous Lipomatosis: A Case With Long Term Follow-up.
Bauld H; McNeely PD
Can J Neurol Sci; 2014 Jan; 41(1):106-8. PubMed ID: 24384349
[No Abstract] [Full Text] [Related]
69. Encephalocraniocutaneous Lipomatosis (Haberl and syndrome): A case report and review of literature.
Koti K; Bhimireddy V; Dandamudi S; Gunnamreddy R
Indian J Dermatol; 2013 May; 58(3):232-4. PubMed ID: 23723477
[TBL] [Abstract][Full Text] [Related]
70. [Encephalocraniocutaneous lipomatosis. A non-hereditary mosaic phenotype].
Happle R; Steijlen PM
Hautarzt; 1993 Jan; 44(1):19-22. PubMed ID: 8436503
[TBL] [Abstract][Full Text] [Related]
71. Low-grade astrocytoma in a child with encephalocraniocutaneous lipomatosis.
Brassesco MS; Valera ET; Becker AP; Castro-Gamero AM; de Aboim Machado A; Santos AC; Scrideli CA; Oliveira RS; Machado HR; Tone LG
J Neurooncol; 2010 Feb; 96(3):437-41. PubMed ID: 19652916
[TBL] [Abstract][Full Text] [Related]
72. Encephalocraniocutaneous lipomatosis (Haberland syndrome) with bilateral cutaneous and visceral involvement.
Rubegni P; Risulo M; Sbano P; Buonocore G; Perrone S; Fimiani M
Clin Exp Dermatol; 2003 Jul; 28(4):387-90. PubMed ID: 12823300
[TBL] [Abstract][Full Text] [Related]
73. [Nevus psiloliparus in a child with encephalocraniocutaneous lipomatosis].
Llamas-Velasco M; Hernández A; Colmenero I; Torrelo A
Actas Dermosifiliogr; 2011 May; 102(4):303-5. PubMed ID: 21377639
[No Abstract] [Full Text] [Related]
74. Mosaic Neurocutaneous Disorders and Their Causes.
Ruggieri M; Praticò AD
Semin Pediatr Neurol; 2015 Dec; 22(4):207-33. PubMed ID: 26706010
[TBL] [Abstract][Full Text] [Related]
75. FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly.
Simonis N; Migeotte I; Lambert N; Perazzolo C; de Silva DC; Dimitrov B; Heinrichs C; Janssens S; Kerr B; Mortier G; Van Vliet G; Lepage P; Casimir G; Abramowicz M; Smits G; Vilain C
J Med Genet; 2013 Sep; 50(9):585-92. PubMed ID: 23812909
[TBL] [Abstract][Full Text] [Related]
76. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
[TBL] [Abstract][Full Text] [Related]
77. Pseudodidymosis: nevus psiloliparus with aplasia cutis congenita, an initial manifestation of Haberland syndrome.
Ambooken B; Kesavan A; Neelakandan A; Mathew A
Int J Dermatol; 2018 Dec; 57(12):e160-e162. PubMed ID: 30238439
[No Abstract] [Full Text] [Related]
78. Expanding the clinical phenotype of
Kautto EA; Schieffer KM; McGrath S; Miller AR; Hernandez-Gonzalez ME; Choi S; Conces MR; Fernandez-Faith E; Ho ML; Lee K; Lillis AP; Pearson GD; Kaler SG; Wilson RK; Mardis ER; Magrini V; Leonard J; Cottrell CE
Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35149534
[TBL] [Abstract][Full Text] [Related]
79. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
80. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
